Vaccine News and Research

Latest Vaccine News and Research

Modeling study offers a road map for public health to maximize the impact of monkeypox vaccines

A modeling study to explore optimal allocation of vaccines against monkeypox virus (MPXV) provides a road map for public health to maximize the impact of a limited supply of vaccines.

28 Nov 2022

Are nasal-spray vaccines the solution to respiratory infectious diseases?

A recent study published in the journal Trends in Molecular Medicine reviewed the current efforts in developing nasal vaccines, delivery systems, and clinical applications for preventing respiratory illnesses.

28 Nov 2022

Memory B and T cells responses differ when induced by SARS-CoV-2 infections or booster vaccinations

In a recent study published in The Journal of Immunology, a team of researchers from Japan examined the memory B and T cell responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein after the booster dose of the coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA) vaccine BNT162b2.

27 Nov 2022

Nanoparticles displaying SARS-CoV-1 and SARS-CoV-2 spikes induce broad antibody responses in animal model

A recent study published in the journal iScience reported that nanoparticles (NPs) co-displaying spike proteins from different sarbecoviruses improve the breadth of neutralizing responses.

27 Nov 2022

Government introduces a Vaccine Taskforce style approach to tackle public health challenges in the UK

NHS patients are set to benefit from cutting-edge new treatments and technologies as the government introduces a Vaccine Taskforce style approach to tackling some of the biggest public health challenges facing the UK.

27 Nov 2022

Scientists develop preclinical model of scrub typhus disease

Scientists have developed an animal model of scrub typhus using outbred CD-1 mice. Using the model, they have characterized host susceptibility to the causative pathogen, disease pathogenesis, and immune responses. The study has been published in the journal PLOS Neglected Tropical Diseases.

27 Nov 2022

All trimesters of pregnancy carry the same COVID-19 risk

A study in the American Journal of Obstetrics & Gynecology MFM journal aimed to analyze the effect of the trimester of SARS-CoV-2 infection on the progression of the disease in pregnant women.

27 Nov 2022

Boosting Africa's capacity to manufacture vaccines

Africa produces only one per cent of its routine vaccines. This leaves the region dependent on imports for its vaccine needs, and makes it vulnerable to a vaccine crisis during health emergencies.

25 Nov 2022

Multivalent mRNA-based vaccine may serve as a preventative measure against future flu pandemics

An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in initial tests, and thus might serve one day as a general preventative measure against future flu pandemics, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.

25 Nov 2022

New approach may serve as the basis for universal flu vaccines

Claudia Arevalo and colleagues have developed a mRNA lipid nanoparticle vaccine that contains antigens from all 20 known subtypes of influenza A and B viruses, a strategy that may serve as the basis for universal flu vaccines.

24 Nov 2022

All eligible people urged to get vaccinated due to higher rates of flu cases than usual

All those eligible for the flu vaccine have been urged to come forward as cases rise to levels not seen since before the pandemic.

24 Nov 2022

AI helps design synthetic DNA that controls cells' protein production

With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells' protein production.

24 Nov 2022

What was the return on investment of the COVID-19 vaccination campaign in New York City?

A recent study estimated the return on investment (ROI) of New York City’s coronavirus disease 2019 (COVID-19) vaccination campaign.

24 Nov 2022

Do previously infected individuals still benefit from vaccination against COVID-19?

Researchers determined the vaccine effectiveness (VE) of the primary coronavirus disease 2019 (COVID-19) vaccination series.

24 Nov 2022

The relationship between neutralization levels and observed efficacies against asymptomatic and symptomatic infection of ten COVID-19 vaccines

Researchers determined whether neutralizing antibody levels were predictive of the efficacy of fractional vaccine doses against SARS-CoV-2 infection.

24 Nov 2022

Study highlights global estimates of mortality related to 33 clinically significant bacterial pathogens

Researchers presented comprehensive global estimates of the mortality burden related to 33 species or genera of bacterial pathogenic organisms causing 11 main infectious syndromes in 2019 using data and methods of the GBD 2019 and the global burden of antimicrobial resistance study conducted in the same year.

24 Nov 2022

Vaccine News and Research

Latest Vaccine News and Research

Modeling study offers a road map for public health to maximize the impact of monkeypox vaccines

Are nasal-spray vaccines the solution to respiratory infectious diseases?

Memory B and T cells responses differ when induced by SARS-CoV-2 infections or booster vaccinations

Nanoparticles displaying SARS-CoV-1 and SARS-CoV-2 spikes induce broad antibody responses in animal model

Government introduces a Vaccine Taskforce style approach to tackle public health challenges in the UK

Scientists develop preclinical model of scrub typhus disease

All trimesters of pregnancy carry the same COVID-19 risk

Boosting Africa's capacity to manufacture vaccines

Multivalent mRNA-based vaccine may serve as a preventative measure against future flu pandemics

New approach may serve as the basis for universal flu vaccines

All eligible people urged to get vaccinated due to higher rates of flu cases than usual

AI helps design synthetic DNA that controls cells' protein production

What was the return on investment of the COVID-19 vaccination campaign in New York City?

Do previously infected individuals still benefit from vaccination against COVID-19?

The relationship between neutralization levels and observed efficacies against asymptomatic and symptomatic infection of ten COVID-19 vaccines

Study highlights global estimates of mortality related to 33 clinically significant bacterial pathogens

Study demonstrates that Paxlovid protects severe COVID-19–associated outcomes among persons for whom it is recommended

COVID-19 disparities more likely to negatively impact Black and Hispanic men

COVID-19 vaccination provides 60% to 94% protection against reinfection

Bivalent mRNA vaccines could enhance protective efficacy against COVID-19

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in